TipRanks

Mark Baum Insider Profile

11 Followers
Mark Baum, CEO, Director at Harrow Health, holds 3.00M shares in Harrow Health (Ticker: HROW), holds ― shares in Eton Pharmaceuticals (Ticker: ETON), holds 54.96K shares in Ideal Power (Ticker: IPWR). Most recently, Mark Baum Bought ― shares of Harrow Health on May 15, 2026 for an estimated value of $302.00K.
tipranks
Mark Baum

Mark Baum
Harrow Health (HROW)
CEO, Director

Ranked #2,590 out of 109,349 Corporate Insiders

Profitable Transactions

56%
5 out of 9 Profitable Transactions

Average Return

+63.00%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$85M
99.83%
0.17%
0.00%
A breakdown of Mark Baum's holdings

Insider Roles

Harrow Health
(HROW)
CEO, Director
Ideal Power
(IPWR)
Director
Eton Pharmaceuticals
(ETON)
Director
Roles that Mark Baum holds in companies

Most Profitable Insider Trade

Stock:
Harrow Health
(HROW)
Rating:Informative Buy
Date:Nov 16, 2023 - Nov 16, 2024
Return:+353.60%
The most profitable trade made by Mark Baum

Mark Baum's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Harrow Health
May 15, 2026
CEO, Director
Informative Buy
302.00K
$84.61M
Eton Pharmaceuticals
―
Director
―
―
Ideal Power
Mar 06, 2017
Director
Informative Buy
19.73K
$144.55K
CEMI
Chembio Diagnostics
―
―
―
$6.83M
List of latest transactions for each holding click on a transaction to see Mark Baum's performance on stock

Mark Baum insider profile FAQ

What is the percentage of profitable transactions made by Mark Baum?
The percentage of profitable transactions made by Mark Baum is 56%.
    What is the average return per transaction made by Mark Baum?
    The average return per transaction made by Mark Baum is 63.00%.
      What stocks does Mark Baum hold?
      Mark Baum holds: HROW, ETON, IPWR, CEMI stocks.
        What was Mark Baum’s latest transaction?
        Mark Baum latest transaction was an Informative Buy of $302.00K.
          What was Mark Baum's most profitable transaction?
          Mark Baum’s most profitable transaction was an Informative Buy of HROW stock on November 16, 2023. The return on the trade was 353.60%.
            What is Mark Baum's role in Harrow Health?
            Mark Baum's role in Harrow Health is CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.